Chronic prurigo: Insufficient disease control in spite of high healthcare usage.

(a) Number of ambulatory visits (n = 441), inpatient stays (n = 339) and inpatient stay days (n = 166) per patient due to chronic prurigo in per cent and absolute numbers. y-axis: number of patients. Dermatologists treating adult CPG patients at 14 dermatological centres across 12 European countries completed a questionnaire for each patient. Chronic prurigo (CPG) is a highly pruritic, debilitating disease,[1] complex to treat,[2] with an estimated prevalence of 8.4-210/100,000.[3] Patients are mostly treated by dermatologists and general practitioners, with 33.8% of patients receiving at least one systemic and 45.1% one topical prescription drug.[4] We investigated healthcare utilization and treatment patterns across Europe in a prospective, multicentre study. [Extracted from the article]